RETRACTED: LSAMP-AS1 binds to microRNA-183–5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN-Reference-Cited by-同舟云学术

RETRACTED: LSAMP-AS1 binds to microRNA-183–5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN

Published:2019-12 Issue: Volume:50 Page:178-190
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Hua Xing,Liu Zhen,Zhou Min,Tian Yan,Zhao Pei-Pei,Pan Wen-Hai,Li Chao-Xia,Huang Xiao-Xiao,Liao Ze-Xiao,Xian Qi,Chen Bo,Hu Yue,Leng Lei,Fang Xiao-Wei,Yu Li-Na^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Biomarkers in prostate cancer - Current clinical utility and future perspectives;Kretschmer;Crit Rev Oncol Hematol,2017

3. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study;Nam;Lancet Oncol,2014

4. Long-term functional outcomes after treatment for localized prostate cancer;Resnick;N Engl J Med,2013

5. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retraction Note: MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression;Cancer Cell International;2024-04-30

2. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer;Cancer Cell International;2023-10-19

3. Analysis of Genetic Biomarkers, Polymorphisms in ADME-Related Genes and their Impact on Pharmacotherapy for Prostate Cancer;2023-08-17

4. MiR-183-5p Promotes the Cell Proliferation of Colorectal Cancer by Targeting QKI-5;2022-12-05

5. Relationship of biglycan and decorin expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2022-11-04